Fifth Third Wealth Advisors LLC

Position in ABBV — AbbVie Inc.

CIK 1899030 Cincinnati, OH

Position in ABBV

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$12,852,009

+$2,088,864 QoQ

Shares Held

51,073

+3.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

#794

of 4,153 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Fifth Third Wealth Advisors LLC holds $84,923,860 across 10 Drug Manufacturers - General names. ABBV ranks #3 (15.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,068	$30,067,313
2	JNJ	Johnson & Johnson	57,925	$14,711,212
3	ABBV	AbbVie Inc. This page	51,073	$12,852,009
4	MRK	Merck & Co., Inc.	73,198	$9,405,943
5	PFE	Pfizer Inc	205,404	$4,946,128
6	GILD	Gilead Sciences, Inc.	33,341	$4,212,301
7	BMY	Bristol Myers Squibb Co	65,413	$3,769,097
8	AMGN	Amgen Inc	9,260	$3,353,231

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,852,009	51,073	+3.2%	Shares	Sole	2026-07-17
2026-03-31	$10,763,145	49,488	+4.4%	Shares	Sole	2026-04-20
2025-12-31	$10,832,939	47,411	-0.2%	Shares	Sole	2026-01-15
2025-09-30	$10,999,307	47,505	+1.9%	Shares	Sole	2025-10-21
2025-06-30	$8,652,861	46,616	-8.9%	Shares	Sole	2025-07-25
2025-03-31	$10,718,624	51,158	+16.9%	Shares	Sole	2025-04-08
2024-12-31	$7,778,106	43,771	-0.8%	Shares	Sole	2025-01-14
2024-09-30	$8,715,187	44,132	+14.7%	Shares	Sole	2024-11-07
2024-06-30	$6,602,147	38,492	+23.6%	Shares	Sole	2024-07-23
2024-03-31	$5,671,140	31,143	+26.4%	Shares	Sole	2024-04-16
2023-12-31	$3,817,530	24,634	+7.1%	Shares	Sole	2024-01-08
2023-09-30	$3,429,423	23,007	+39.3%	Shares	Sole	2023-10-17
2023-06-30	$2,225,200	16,516	+173.9%	Shares	Sole	2023-07-25
2023-03-31	$960,841	6,029	—	Shares	Sole	2023-04-27
No filing history on record for this holder in this stock.